Corcept Therapeutics (NASDAQ:CORT) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Corcept Therapeutics beat estimated earnings by 7.69%, reporting an EPS of $0.28 versus an estimate of $0.26.
Revenue was up $32.35 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 9.97% drop in the share price the next day.
Here's a look at Corcept Therapeutics's past performance:
To track all earnings releases for Corcept Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
